Clinical practice decision tree for the choice of the first disease modifying antirheumatic drug for very early rheumatoid arthritis: A 2004 proposal of the French Society of Rheumatology

Annals of the Rheumatic Diseases

Volumn 65, Issue 1, 2006, Pages 45-50

  Le Loët, Xavier ^a   Berthelot, J M ^b   Cantagrel, A ^c   Combe, B ^d   De Bandt, M ^e   Fautrel, B ^f   Flipo, R M ^g   Liote F ^h   Maillefert, J F ⁱ   Meyer, O ^e   Saraux, A ^j   Wendling, D ^k   Guillemin, F ^l  

^a ROUEN UNIVERSITY HOSPITAL   (France)

^b NANTES UNIVERSITY HOSPITAL   (France)

^c TOULOUSE UNIVERSITY HOSPITAL   (France)

^d MONTPELLIER UNIVERSITY HOSPITAL   (France)

^e BICHAT HOSPITAL   (France)

^f PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^g LILLE UNIVERSITY HOSPITAL   (France)

^h Lariboisière Paris University Hospital   (France)

ⁱ DIJON UNIVERSITY HOSPITAL   (France)

^j BREST UNIVERSITY HOSPITAL   (France)

^k UNIVERSITY HOSPITAL OF BESANÇON   (France)

^l UNIVERSITY HOSPITAL OF NANCY   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; AURANOFIN; AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN A; DISEASE MODIFYING ANTIRHEUMATIC DRUG; ETANERCEPT; GOLD SALT; HYDROXYCHLOROQUINE; INFLIXIMAB; LEFLUNOMIDE; METHOTREXATE; MINOCYCLINE; PENICILLAMINE; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; RHEUMATOID FACTOR; SALAZOSULFAPYRIDINE; TIOPRONIN;

ARTICLE; CLINICAL PRACTICE; DISEASE ACTIVITY; DISEASE ASSOCIATION; DRUG CHOICE; HUMAN; MEDICAL DECISION MAKING; MEDICAL INFORMATION; PHYSICIAN; PRIORITY JOURNAL; PROGNOSIS; PUBLISHING; RHEUMATOID ARTHRITIS;

ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; BIOLOGICAL MARKERS; CHOICE BEHAVIOR; DECISION TREES; FRANCE; HUMANS; PRACTICE GUIDELINES; RHEUMATOID FACTOR; SEVERITY OF ILLNESS INDEX; SOCIETIES, MEDICAL; TREATMENT OUTCOME;

EID: 29144467890     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2005.035436     Document Type: Article

References (25)

1. Guillemin F, Saraux A, Guggenbuhl P, Roux CH, Fardellone P, Le Bihan E, et al. Prevalence of rheumatoid arthritis in France - 2001. Ann Rheum Dis, 2005, Mar 30 [epub ahead of print]..
2. Gabriel SE. The epidemiology of rheumatoid arthritis. Rheum Dis Clin North Am 2001;27:269-81.
3. Mottonen T, Hannonen P, Korpela M, Nissila M, Kautiainen H, Ilonen J, et al. Delay of institution of therapy and induction of remission using single-drug or combination disease-modifying antirheumatic drug therapy in early rheumatoid arthritis. Arthritis Rheum 2002;46:894-8.
4. Albers JM, Paimela L, Kurki P, Eberhardt KB, Emery P, van't Hof MA, et al. Treatment strategy, disease activity, and outcome in four cohorts of patients with early rheumatoid arthritis. Ann Rheum Dis 2001;60:453-8.
5. Lard LR, Boers M, Verhoeven A, Vos K, Visser H, Hazes JM, et al. Early and aggressive treatment of rheumatoid arthritis patients affects the association of HLA class II antigens with progression of joint damage. Arthritis Rheum 2002;46:899-905.
6. American College of Rheumatology Subcommittee on Rheumatoid Arthritis Guidelines. Guidelines for the management of rheumatoid arthritis: 2002 update. Arthritis Rheum 2002;46:328-46.
7. Shekelle PG, Woolf SH, Eccles M, Grimshaw J. Clinical guidelines: developing guidelines. BMJ 1999;318:593-6.
8. Anon. Strategies therapeutiques de la polyarthrite rhumatoide. Etude critique de la litterature consacree aux traitements de fond de la polyarthrite rhumatoide. Rev Rhum Ed Fr 2002;69(suppl 2):21-100.
9. Emery P, Breedveld FC, Dougados M, Kalden JR, Schiff MH, Smolen JS. Early referral recommendation for newly diagnosed rheumatoid arthritis: evidence based development of a clinical guide. Ann Rheum Dis 2002;61:290-7.
10. Le Loet X. Utility of early prognosis in rheumatoid arthritis. Rev Rhum 2004;71:28-33s.
11. Dalkey N, Helmer O. An experimental application of the Delphi method to the use of experts. Management Science 1963;9:458-67.
12. Thurstone LL. A law of comparative judgement. Psychol Rev 1927;34:273-86.
13. Prevoo ML, van't Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL. Modified disease activity scores that include twenty-eight joint counts. Arthritis Rheum 1995;38:44-8.
14. Felson DT, Anderson JJ, Boers M, Bombardier C, Furst D, Goldsmith C, et al. The American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis. Arthritis Rheum 1995;38:727-35.
15. Scott DL. The diagnosis and prognosis of early arthritis: rationale for new prognostic criteria. Arthritis Rheum 2002;46:286-90.
16. van der Heijde DM, van Riel PL, van Leewen MA, van Thof MA, van Rijjwijk MH, van de Putte LB. Prognostic factors for radiographic damage and physical disability in early rheumatoid arthritis. A prospective follow-up of 147 patients. Br J Rheumatol 1992;31:519-25.
17. van der Heide A, Remme CA, Hofman DM, Jacobs JW, Bijcsma JW. Prediction of progression of radiologic damage in newly diagnosed rheumatoid arthritis. Arthritis Rheum 1995;38:1466-74.
18. van Leuwen MA, Wiestra J, van Riel PL. IgM, IgA and IgG rheumatoid factors in early rheumatoid arthritis are predictive of radiological progression. Scand J Rheumatol 1995;24:146-53.
19. Wolfe F, Rehman Q, Lane NE, Kremer J. Starting a disease modifying antirheumatic drug or a biologic agent in rheumatoid arthritis: standards of practice for RA treatment. J Rheumatol 2001;28:1704-11.
20. Garnero P, Landewe R, Boers M, Verhoeven A, van der Linden S, Christgau S, et al. Association of baseline levels of markers of bone and cartilage degradation with long-term progression of joint damage in patients with early rheumatoid arthritis: the COBRA study. Arthritis Rheum 2002;46:2847-56.
21. Drossaers-Bakker KW, Zwinderman AH, Vlieland TP, van Zeben D, Vos K, Breedveld FC, et al. Long-term outcome in rheumatoid arthritis: a simple algorithm of baseline parameters can predict radiographic damage, disability, and disease course at 12-year follow up. 4rthritis Rheum 2002;47:383-90.
22. Visser H, Le Cessie S, Vos K, Breedveld FC, Hazes JM. How to diagnose rheumatoid arthritis early: model for persistent (erosive) arthritis. Arthritis Rheum 2002;46:357-65.
23. Scottish Intercollegiate Guidelines Network. Management of early rheumatoid arthritis. Edinburgh: SIGN 2000 (SIGN Publication No 8), http://www.sign.ac.uk.
24. Smolen JS, Sokka T, Pincus T, Breedveld FC. A proposed treatment algorithm for rheumatoid arthritis: aggressive therapy, methotrexate, and quantitative measures. Clin Exp Rheumatol 2004;21(suppl 31):S209-10.
25. Grigor C, Capell H, Stirling A, McMahon AD, Lock P, Vallance R, et al. Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomized controlled trial. Lancet 2004;364:263-9.